Biomarkers associated with pulse pressure in African-Americans and non-hispanic whites

American Journal of Hypertension

Volumn 25, Issue 2, 2012, Pages 145-151

  Coutinho, Thais ^a   Turner, Stephen T ^a   Mosley, Thomas H ^b   Kullo, Iftikhar J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

adrenomedullin; arterial stiffness; atrial natriuretic peptide; biomarkers; blood pressure; brain natriuretic peptide; fibrinogen; hypertension; matrix metalloproteinase 2; osteoprotegerin; pulse pressure

Indexed keywords

ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN; FIBRINOGEN; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 27; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; OSTEOPONTIN; OSTEOPROTEGERIN; PADGEM PROTEIN; PROADRENOMEDULLIN; SERUM AMYLOID A; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AFRICAN AMERICAN; AGED; ARTERIOSCLEROSIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SPHYGMOMANOMETER;

ADRENOMEDULLIN; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ARTERIOSCLEROSIS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRINOGEN; HUMANS; HYPERTENSION; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; VASCULAR STIFFNESS;

EID: 84856050210     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.193     Document Type: Article

References (40)

1. Nichols W. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. Arnold 4th Ed. London, UK, 1998 , pp. 54-401.
2. Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation 2001; 104:783-789. (Pubitemid 32762676)
3. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31:1865-1871.
4. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23:395-401. (Pubitemid 24076725)
5. Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, D'Agostino RB Sr, Kannel WB, Levy D, Benjamin EJ. Pulse pressure and risk of new-onset atrial fibrillation. JAMA 2007; 297:709-715. (Pubitemid 46294560)
6. Vaccarino V, Berger AK, Abramson J, Black HR, Setaro JF, Davey JA, Krumholz HM. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 2001; 88:980-986. (Pubitemid 33042608)
7. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281:634-639. (Pubitemid 29098064)
8. Waldstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 2008; 51:99-104. (Pubitemid 350307110)
9. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123:e18-e209.
10. Mayet J, Shahi M, Foale RA, Poulter NR, Sever PS, McG Thom SA. Racial differences in cardiac structure and function in essential hypertension. BMJ 1994; 308: 1011-1014. (Pubitemid 24115035)
11. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 1988; 12:285-290.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
13. Kim CX, Bailey KR, Klee GG, Ellington AA, Liu G, Mosley TH Jr, Rehman H, Kullo IJ. Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS ONE 2010; 5:e9065.
14. Lieb W, Larson MG, Benjamin EJ, Yin X, Tofler GH, Selhub J, Jacques PF, Wang TJ, Vita JA, Levy D, Vasan RS, Mitchell GF. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation 2009; 119:37-43.
15. Yambe M, Tomiyama H, Koji Y, Motobe K, Shiina K, Gulnisia Z, Yamamoto Y, Yamashina A. B-type natriuretic peptide and arterial stiffness in healthy Japanese men. Am J Hypertens 2006; 19:443-447.
16. Xu-Cai YO, Wu Q. Molecular forms of natriuretic peptides in heart failure and their implications. Heart 2010; 96:419-424.
17. Niederkofler EE, Kiernan UA, O'Rear J, Menon S, Saghir S, Protter AA, Nelson RW, Schellenberger U. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circ Heart Fail 2008; 1:258-264.
18. Al-Omari MA, Khaleghi M, Mosley TH Jr, Turner ST, Morgenthaler NG, Struck J, Bergmann A, Kullo IJ. Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertension. Am J Hypertens 2009; 22:860-866.
19. Levy D, Hwang SJ, Kayalar A, Benjamin EJ, Vasan RS, Parise H, Larson MG, Wang TJ, Selhub J, Jacques PF, Vita JA, Keyes MJ, Mitchell GF. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study. Circulation 2007; 115:3079-3085. (Pubitemid 46956497)
20. Kita T, Kitamura K, Hashida S, Morishita K, Eto T. Plasma adrenomedullin is closely correlated with pulse wave velocity in middle-aged and elderly patients. Hypertens Res 2003; 26:887-893. (Pubitemid 37508966)
21. Kato J, Tsuruda T, Kita T, Kitamura K, Eto T. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005; 25:2480-2487. (Pubitemid 43732267)
22. Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F, Oya H, Kyotani S, Nakanishi N, Goto Y, Masuda Y, Miyatake K, Kangawa K. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 2000; 101:498-503. (Pubitemid 30080863)
23. Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S, Siepi D, Bagaglia F, Mannarino E. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 2003; 21: 1841-1846. (Pubitemid 37290102)
24. Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy PF 2nd, Peyser PA, Turner ST. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 2005; 18: 1123-1129. (Pubitemid 41139913)
25. Asferg C, Jensen JS, Marott JL, Appleyard M, Møgelvang R, Jensen GB, Jeppesen J. Markers of inflammation and hemodynamic measurements in obesity: Copenhagen City Heart Study. Am J Hypertens 2009; 22:451-456.
26. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109:112-110.
27. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schönbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000; 36:878-884.
28. Vlachopoulos C, Aznaouridis K, Dima I, Ioakeimidis N, Vasiliadou C, Zervoudaki A, Gialernios T, Stefanadis C. Negative association between serum levels of matrix metalloproteinases-2 and-9 and aortic stiffness in healthy adults. Int J Cardiol 2007; 122:232-238. (Pubitemid 47615187)
29. Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, Wilkinson IB. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 372.
30. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90:251-262. (Pubitemid 34633925)
31. Palmieri V, Celentano A, Roman MJ, de Simone G, Lewis MR, Best L, Lee ET, Robbins DC, Howard BV, Devereux RB. Fibrinogen and preclinical echocardiographic target organ damage: the strong heart study. Hypertension 2001; 38:1068-1074. (Pubitemid 34252807)
32. Sie MP, Isaacs A, de Maat MP, Mattace-Raso FU, Uitterlinden AG, Kardys I, Hofman A, Hoeks AP, Reneman RS, van Duijn CM, Witteman JC. Genetic variation in the fibrinogen-α and fibrinogen-gamma genes in relation to arterial stiffness: the Rotterdam Study. J Hypertens 2009; 27:1392-1398.
33. Herrick S, Blanc-Brude O, Gray A, Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999; 31:741-746. (Pubitemid 29333117)
34. Lund T, Osterud B. Fibrinogen increases lipopolysaccharide-induced tumor necrosis factor-α and interleukin-8 release, and enhances tissue factor activity in monocytes in a modified whole blood system. Blood Coagul Fibrinolysis 2001; 12:667-675. (Pubitemid 33139686)
35. Kim SM, Lee J, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clin Endocrinol (Oxf ) 2005; 63:594-598. (Pubitemid 41626757)
36. Schnabel R, Larson MG, Dupuis J, Lunetta KL, Lipinska I, Meigs JB, Yin X, Rong J, Vita JA, Newton-Cheh C, Levy D, Keaney JF Jr, Vasan RS, Mitchell GF, Benjamin EJ. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension 2008; 51:1651-1657.
37. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12:1260-1268. (Pubitemid 28213402)
38. Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM. Osteoprotegerin is an αvβ3-induced, NF-κB-dependent survival factor for endothelial cells. J Biol Chem 2000; 275:20959-20962. (Pubitemid 30481782)
39. Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 2004; 109:2175-2180. (Pubitemid 38625393)
40. Mitchell GF, Wang N, Palmisano JN, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS. Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the Framingham Heart Study. Circulation 2010; 122:1379-1386.